Global Gene Therapy Market to 2027: Technological Advancements in Genomics and Gene-Editing Tools Drives Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Gene Therapy Market to 2027” report has been added to ResearchAndMarkets.com’s offering.

Gene therapy is a type of experimental technique in which genes are used to treat or prevent diseases. In this therapy genes are inserted into patient’s cells instead of using surgery and drugs. Gene therapy has various approaches such as replacement of muted gene, inactivating or knocking out a muted gene, and introducing new gene into the body to help fight a disease.

Global Gene Therapy Market Drivers

Increase in prevalence of chronic diseases like cancer is expected to boost the global gene therapy market, in this forecast period. Furthermore, technological advancements in genomics and gene-editing tools will have a positive impact on gene therapy market growth. Rapid and significant progress in the molecular and cellular biology arena is also expected to propel the global gene therapy market growth. Moreover, rise in product approval is expected to fuel the global gene therapy market growth.

Global Gene Therapy Market Restraints

However, high cost is the major restraining factor which is expected to hamper the global gene therapy market growth. Also, lack of skilled professionals is expected to affect the global gene therapy market growth.

Global Gene Therapy Market Taxonomy

By Types

  • Viral Sector
  • Nonviral Sector

By Gene Type

  • Antigen
  • Cytokine
  • Growth Factors
  • Receptors
  • Others

By Application

  • Oncological Disorder
  • Cardiovascular Diseases
  • Neurological Disorders
  • Rare Diseases
  • Infectious Diseases
  • Others

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Key Topics Covered:

1. Executive Summary

1.1. Market Taxonomy

2. Global Gene Therapy Market Demand (in Value or Size in US$ Mn) Analysis and Forecast

3. Market Background

3.1. Forecast Factor

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Challenges

3.2.3. Trends

4. Global Gene Therapy Market Snapshot

5. Global Gene Therapy Market Analysis, By Types

5.1. Y-o-Y Growth Comparison, By Types

5.2. Global Gene Therapy Market Share Analysis, By Types

5.3. Global Gene Therapy Market Size and Forecast, By Types

5.3.1 Viral Sector

5.3.2 Nonviral Sector

6. Global Gene Therapy Market Analysis, By Gene Type

6.1. Y-o-Y Growth Comparison, By Gene Type

6.2. Global Gene Therapy Market Share Analysis, By Gene Type

6.3. Global Gene Therapy Market Size and Forecast, By Gene Type

6.3.1 Antigen

6.3.2 Cytokine

6.3.3 Growth Factors

6.3.4 Receptors

6.3.5 Others

7. Global Gene Therapy Market Analysis, By Application

7.1. Y-o-Y Growth Comparison, By Application

7.2. Global Gene Therapy Market Share Analysis, By Application

7.3. Global Gene Therapy Market Size and Forecast, By Application

7.3.1 Oncological Disorder

7.3.2 cardiovascular diseases

7.3.3 Neurological Disorders

7.3.4 Rare Diseases

7.3.5 Infectious Diseases

7.3.6 Others

8. Global Gene Therapy Market Analysis, By Region

8.1. Y-o-Y Growth Comparison, By Region

8.2. Global Gene Therapy Market Share Analysis, By Region

9. North America Gene Therapy Market Analysis and Forecast (2017-2027)

9.1 Introduction

9.2 North America Gene Therapy Market Analysis, By Types

9.3 North America Gene Therapy Market Analysis, By Gene Type

9.4 North America Gene Therapy Market Analysis, By Application

9.5 North America Gene Therapy Market Analysis, By Country

9.5.1 USA

9.5.2 Canada

9.5.3 Mexico

10. Europe Gene Therapy Market Analysis and Forecast (2017-2027)

10.1 Introduction

10.2 Europe Gene Therapy Market Analysis, By Types

10.3 Europe Gene Therapy Market Analysis, By Gene Type

10.4 Europe Gene Therapy Market Analysis, By Application

10.5 Europe Gene Therapy Market Analysis, By Country

10.5.1 Germany

10.5.2 France

10.5.3 UK

10.5.4 Rest of Europe

11. Asia Pacific Gene Therapy Market Analysis and Forecast (2017-2027)

11.1 Introduction

11.2 Asia Pacific Gene Therapy Market Analysis, By Types

11.3 Asia Pacific Gene Therapy Market Analysis, By Gene Type

11.3 Asia Pacific Gene Therapy Market Analysis, By Application

11.4 Asia Pacific Gene Therapy Market Analysis, By Country

11.4.1 China

11.4.2 India

11.4.3 Japan

11.4.4 Rest of Asia Pacific

12. Latin America Gene Therapy Market Analysis and Forecast (2017-2027)

12.1 Introduction

12.2 Latin America Gene Therapy Market Analysis, By Types

12.3 Latin America Gene Therapy Market Analysis, By Gene Type

12.4 Latin America Gene Therapy Market Analysis, By Application

13. Middle East & Africa Gene Therapy Market Analysis and Forecast (2017-2027)

13.1 Introduction

13.2 Middle East & Africa Gene Therapy Market Analysis, By Types

13.3 Middle East & Africa Gene Therapy Market Analysis, By Gene Type

13.4 Middle East & Africa Gene Therapy Market Analysis, By Application

14. Competition Analysis

14.1 Competition Dashboard

14.2 Market Share Analysis of Top Vendors

14.3 Key Development Strategies

15. Company Profiles

Companies Mentioned

  • BIGEN
  • Gilead Sciences Inc.
  • Amgen
  • Novartis AG
  • Bluebird Bio Inc
  • Orchard Therapeutics Plc
  • Spark Therapeutics
  • Human Stem cell Institutes
  • JAZZ Pharmaceuticals
  • Sibiono Genetech Co Ltd
  • UNIQURE N.V
  • Mustang Bio
  • Poseida Therapeutics Inc.

For more information about this report visit https://www.researchandmarkets.com/r/yc5wmb

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900